148 The effect of body mass index on serum n-terminal pro-b-type natriuretic peptide (2024)

148 The effect of body mass index on serum n-terminal pro-b-type natriuretic peptide (1)

  • Subscribe
  • Log In More

    Log in via Institution

    Log in via OpenAthens

    Log in via BCS

    Log in using your username and password

  • Basket
  • Search More

    Advanced search

You are here

  • Home
  • Archive
  • Volume 110,Issue Suppl 3
  • 148 The effect of body mass index on serum n-terminal pro-b-type natriuretic peptide

Email alerts

  • Article Text
  • Article info
  • Citation Tools
  • Share
  • Rapid Responses
  • Article metrics
  • Alerts

PDF

Heart failure

148 The effect of body mass index on serum n-terminal pro-b-type natriuretic peptide

Free

  1. Elton Luo1,
  2. Joe Cuthbert1,
  3. Syed Kazmi2,
  4. Alan Rigby2,
  5. Andrew Clark2
  1. 1Hull University Teaching Hospitals NHS Trust, Castle Hill Hospital, Castle Road, Cottingham, ERY HU16 5JQ, UK
  2. 2Hull York Medical School

Abstract

Introduction Obesity is associated with lower natriuretic peptide (NP) levels, which has implications for the diagnosis of heart failure (HF). It might be that the lower NP is due to obese subjects becoming symptomatic with lesser degrees of left ventricular dysfunction than normal weight subjects. We therefore explored the relation between body mass, left ventricular dysfunction and NT-proBNP in a large cohort of patients being investigated for possible HF.

Methods We report on 2866 patients referred with suspected HF to a community heart failure clinic between January 2001 and September 2023. All patients had BMI, NT-proBNP, and covariate baseline values (age, sex, creatinine, left ventricular ejection fraction (LVEF), New York Heart Association (NYHA) class, and cardiac rhythm). Patients were categorised as ‘lean’ BMI <25 kg/m2, ‘overweight’ BMI 25–29.9 kg/m2, and ‘obese’ BMI ≥30 kg/m2. NYHA class III and IV were combined to ensure comparable sample sizes.

Results The mean age was 71 ± 11 years, 63% male, mean BMI was 29 ± 6 kg/m2, and mean LVEF was 47 ± 14%. Around one-third had LVEF ≤40%. There were fewer patients with LVEF ≤40% in higher BMI categories (p <0.05). A quarter were in NYHA class III-IV. The median NT-proBNP level was 633 (170 – 1957) ng/L. Hypertension was common, especially in higher BMI categories (p <0.05). The median creatinine level was 95 (79 – 119) μmol/L.

There was an inverse relation between NT-proBNP and BMI: median (25th and 75th centile) NT-proBNP was: 1269 (324 – 3451) ng/L, 643 (171 – 1886) ng/L, and 402 (137 – 1244) ng/L in lean, overweight, and obese groups respectively (p <0.001). Within each NYHA class, there was an inverse relation between log NT-proBNP and LVEF across different BMI categories, with similar slope coefficients (-0.064 to -0.040, p <0.001). However, for any given LVEF, log NT-proBNP level was lower in higher BMI groups. Average intercepts on a plot with LVEF on the X axis and log NT-proBNP on the Y were 9.3, 8.7, and 8.2 kg/m2 in lean, overweight, and obese categories respectively (p <0.001).

There was an inverse relation between BMI as a continuous variable and NT-proBNP in the multivariable regression model (p <0.001). Each one unit increase in BMI (1 kg/m2) was associated with a 3% lower NT-proBNP level (p <0.001). Each SD increase in BMI (5.7 kg/m2 in our sample) was associated with a 10% lower NT-proBNP level (p <0.001). Age, sex, creatinine, LVEF, presence or absence of NYHA III-IV, and presence or absence of atrial fibrillation were also independent predictors of NT-proBNP levels (p <0.001). Among all the independent predictors identified, BMI had the weakest association with NT-proBNP.

Conclusion In patients referred for suspected HF, there is an inverse relation between BMI and NT-proBNP. The effect remains clinically significant even when relevant confounders are considered.

  • Download figure
  • Open in new tab
  • Download powerpoint

Abstract 148 Figure 1

Scatterplots with regression lines of loge NT-proBNP against left ventricular EF across three BMI groups, stratified by NYHA classes

Conflict of Interest None

  • Natriuretic peptides
  • Obesity
  • Body mass index

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    • Natriuretic peptides
    • Obesity
    • Body mass index

    Read the full text or download the PDF:

    Subscribe

    Log in via Institution

    Log in via OpenAthens

    Log in via BCS

    Log in using your username and password

    148 The effect of body mass index on serum n-terminal pro-b-type natriuretic peptide (2024)

    References

    Top Articles
    Latest Posts
    Article information

    Author: Foster Heidenreich CPA

    Last Updated:

    Views: 5991

    Rating: 4.6 / 5 (56 voted)

    Reviews: 95% of readers found this page helpful

    Author information

    Name: Foster Heidenreich CPA

    Birthday: 1995-01-14

    Address: 55021 Usha Garden, North Larisa, DE 19209

    Phone: +6812240846623

    Job: Corporate Healthcare Strategist

    Hobby: Singing, Listening to music, Rafting, LARPing, Gardening, Quilting, Rappelling

    Introduction: My name is Foster Heidenreich CPA, I am a delightful, quaint, glorious, quaint, faithful, enchanting, fine person who loves writing and wants to share my knowledge and understanding with you.